Background Cervical cancer screening programs are poorly implemented in LMICs due to a shortage of specialists and expensive diagnostic infrastructure. To address the barriers of implementation researchers have been developing low-cost portable devices and automating image analysis for decision support.

However, as the knowledge base is growing rapidly, progress on the implementation status of novel imaging devices and algorithms in cervical cancer screening has become unclear. The aim of this project was to provide a systematic review summarizing the full range of automated technology systems used in cervical cancer screening.

Method A search on academic databases was conducted and the search results were screened by two independent reviewers. Study selection was based on eligibility in meeting the terms of inclusion and exclusion criteria which were outlined using a Population, Intervention, Comparator and Outcome framework.

Results 17 studies reported algorithms developed with source images from mobile device, viz. Pocket Colposcope, MobileODT EVA Colpo, Smartphone Camera, Smartphone-based Endoscope System, Smartscope, mHRME, and PiHRME. While 56 studies reported algorithms with source images from conventional/commercial acquisition devices. Most interventions were in the feasibility stage of development, undergoing initial clinical validations.

Conclusion Researchers have proven superior prediction performance of computer aided diagnostics (CAD) in colposcopy (>80% accuracies) versus manual analysis (<70.0% accuracies). Furthermore, this review summarized evidence of the algorithms which are being created utilizing portable devices, to circumvent constraints prohibiting wider implementation in LMICs (such as expensive diagnostic infrastructure). However clinical validation of novel devices with CAD is not yet implemented adequately in LMICs.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes